Tag Archives: hematopoietic stem cell

August, 2017

28 August
CSL Behring to Acquire Calimmune and its Proprietary Stem Cell Gene Therapy Platform

KING OF PRUSSIA, Pa., Aug. 28, 2017 /PRNewswire/ — Global biotherapeutics leader CSL Behring announced today that it has agreed to acquire Calimmune, Inc., a biotechnology company focused on the development of ex vivo hematopoietic stem cell (HSC) gene therapy with R&D facilities in Pasadena, California and Sydney, Australia for …
Share

29 July
Editas Medicine Enters Collaboration with Italian Gene Therapy Institute

CAMBRIDGE, Mass., July 28, 2016 (GLOBE NEWSWIRE) — Editas Medicine, Inc.(NASDAQ:EDIT), a leading genome editing company, and Fondazione Telethon and Ospedale San Raffaele, which operate a joint research collaboration known as the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), have entered into a scientific collaboration to research and develop …
Share

16 March
FDA Approves Spectrum Pharmaceuticals’ Evomela for Injection

HENDERSON, Nev.–(BUSINESS WIRE)– Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today that the U.S. Food and Drug Administration (FDA) has granted approval of EVOMELA for use in two indications: 1) use as a …
Share

22 February
Celldex Presents Preliminary Cohort Data from Pilot Study of its CDX-301

HAMPTON, N.J., Feb. 20, 2016 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today presented new clinical data on CDX-301 (recombinant human Flt3 ligand), a potent hematopoietic cytokine that uniquely expands dendritic cells and hematopoietic stem cells. An open label, pilot study of CDX-301, alone and in combination with Mozobil (plerixafor), …
Share